West Virginia University
Hematology and Oncology fellowship · Morgantown, WV · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is West Virginia University's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
About West Virginia Universityinstitution-wide hematology and oncology research
Hematology and Oncology publications from West Virginia University and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
78
works per year
43rd of 74 hematology and oncology fellowship programs
+16.7%
2-year growth
27th of 74 hematology and oncology fellowship programs
17.0%
in top 10% of field (works before 2025)
54th of 72 hematology and oncology fellowship programs
35.7%
cited above world average
54th of 72 hematology and oncology fellowship programs
Works per year · * 2026 so far
Oncology · 291Hematology · 85
Hematology and Oncology research topics at West Virginia University
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 45
- Cancer survivorship and care 37
- Pancreatic and Hepatic Oncology Research 32
- Colorectal Cancer Treatments and Studies 27
- Acute Myeloid Leukemia Research 23
- Colorectal Cancer Screening and Detection 20
- Cutaneous Melanoma Detection and Management 18
- Multiple Myeloma Research and Treatments 16
Most cited at West Virginia University since 2024
All hematology and oncology papers there on OpenAlex
- Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung CancerArielle Elkrief et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 41
- Loneliness among adult cancer survivors in the United States: prevalence and correlatesChristopher W. Wheldon et al. · Scientific Reports · 2025 · PubMed · cited 35
- Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 TrialsClaire Gallois et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 32
- Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastasesVaseem M. Khatri et al. · npj Breast Cancer · 2024 · PubMed · cited 26
- CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical valueFrancesca Battaglin et al. · Journal for ImmunoTherapy of Cancer · 2024 · PubMed · cited 25
- Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysisRomain Cohen et al. · European Journal of Cancer · 2024 · PubMed · cited 23
- Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and ImmunotherapyJulian Philipp Layer et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · PubMed · cited 23
- Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003Vinai Gondi et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 20
- Management of Iron Deficiency in Heart FailureKazuhiko Kido et al. · JACC Heart Failure · 2024 · PubMed · cited 20
- HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405Francesca Battaglin et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 20